Published in CSH Protoc on June 01, 2006
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev (2002) 8.31
The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer (2002) 4.48
Proteome-scale purification of human proteins from bacteria. Proc Natl Acad Sci U S A (2002) 2.88
Kinase requirements in human cells: III. Altered kinase requirements in VHL-/- cancer cells detected in a pilot synthetic lethal screen. Proc Natl Acad Sci U S A (2008) 2.27
A-type lamins regulate retinoblastoma protein function by promoting subnuclear localization and preventing proteasomal degradation. Proc Natl Acad Sci U S A (2004) 2.17
Kinase requirements in human cells: I. Comparing kinase requirements across various cell types. Proc Natl Acad Sci U S A (2008) 1.95
Polymerization of SopA partition ATPase: regulation by DNA binding and SopB. Mol Microbiol (2006) 1.70
Design of a novel MDM2 binding peptide based on the p53 family. Cell Cycle (2009) 1.52
F plasmid partition depends on interaction of SopA with non-specific DNA. Mol Microbiol (2008) 1.49
The parAB gene products of Pseudomonas putida exhibit partition activity in both P. putida and Escherichia coli. Mol Microbiol (2002) 1.40
Science funding: Provocative questions in cancer research. Nature (2012) 1.36
Feedback contributions to visual awareness in human occipital cortex. Curr Biol (2003) 1.33
ParABS systems of the four replicons of Burkholderia cenocepacia: new chromosome centromeres confer partition specificity. J Bacteriol (2006) 1.33
A kinase shRNA screen links LATS2 and the pRB tumor suppressor. Genes Dev (2011) 1.30
Kinetics of plasmid segregation in Escherichia coli. Mol Microbiol (2004) 1.28
Building a human kinase gene repository: bioinformatics, molecular cloning, and functional validation. Proc Natl Acad Sci U S A (2005) 1.27
Hexamethylene bisacetamide (HMBA) simultaneously targets AKT and MAPK pathway and represses NF kappaB activity: implications for cancer therapy. Cell Cycle (2008) 1.18
Kinase requirements in human cells: II. Genetic interaction screens identify kinase requirements following HPV16 E7 expression in cancer cells. Proc Natl Acad Sci U S A (2008) 1.17
Kinase requirements in human cells: IV. Differential kinase requirements in cervical and renal human tumor cell lines. Proc Natl Acad Sci U S A (2008) 1.12
Efficacy of MedMyst: an Internet Teaching Tool for Middle School Microbiology. Microbiol Educ (2004) 1.12
Upland rice and lowland rice exhibited different PIP expression under water deficit and ABA treatment. Cell Res (2006) 1.11
Dp1 is required for extra-embryonic development. Development (2003) 1.08
Plasmid partition and incompatibility--the focus shifts. Mol Microbiol (2007) 1.08
High-throughput ectopic expression screen for tamoxifen resistance identifies an atypical kinase that blocks autophagy. Proc Natl Acad Sci U S A (2011) 1.07
Mapping of functional domains in F plasmid partition proteins reveals a bipartite SopB-recognition domain in SopA. J Mol Biol (2003) 1.06
Executive function in older adults: a structural equation modeling approach. Neuropsychology (2008) 1.01
Designer combination therapy for cancer. Nat Biotechnol (2006) 1.00
Nuclear reorganization of mammalian DNA synthesis prior to cell cycle exit. Mol Cell Biol (2004) 0.99
Endothelin-1 induces hypertrophy and inhibits apoptosis in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2006) 0.98
Improved electrotransformation and decreased antibiotic resistance of the cystic fibrosis pathogen Burkholderia cenocepacia strain J2315. Appl Environ Microbiol (2009) 0.95
Nucleoside diphosphate kinase Nm23-H1 regulates chromosomal stability by activating the GTPase dynamin during cytokinesis. Proc Natl Acad Sci U S A (2010) 0.94
Probing plasmid partition with centromere-based incompatibility. Mol Microbiol (2005) 0.94
Dual role of DNA in regulating ATP hydrolysis by the SopA partition protein. J Biol Chem (2009) 0.93
Kinase requirements in human cells: V. Synthetic lethal interactions between p53 and the protein kinases SGK2 and PAK3. Proc Natl Acad Sci U S A (2010) 0.93
Concerted action of plasmid maintenance functions: partition complexes create a requirement for dimer resolution. Mol Microbiol (2006) 0.91
Evaluation of Tyro3 expression, Gas6-mediated Akt phosphorylation, and the impact of anti-Tyro3 antibodies in melanoma cell lines. Biochemistry (2013) 0.88
Stapled peptides in the p53 pathway: computer simulations reveal novel interactions of the staples with the target protein. Cell Cycle (2010) 0.88
Lysing tissue-culture cells for immunoprecipitation. CSH Protoc (2006) 0.88
In vitro selection of mutant HDM2 resistant to Nutlin inhibition. PLoS One (2013) 0.87
Protective role for H-NS protein in IS1 transposition. J Bacteriol (2004) 0.87
Inhibition of nutlin-resistant HDM2 mutants by stapled peptides. PLoS One (2013) 0.85
Molecular basis of the supercoil deficit induced by the mini-F plasmid partition complex. J Biol Chem (2008) 0.84
High-throughput screens in diploid cells identify factors that contribute to the acquisition of chromosomal instability. Proc Natl Acad Sci U S A (2010) 0.84
Centromere binding and evolution of chromosomal partition systems in the Burkholderiales. J Bacteriol (2012) 0.84
GRK3 is essential for metastatic cells and promotes prostate tumor progression. Proc Natl Acad Sci U S A (2014) 0.84
Mass medication modeling in response to public health emergencies: outcomes of a drive-thru exercise. J Public Health Manag Pract (2006) 0.83
Centromere binding specificity in assembly of the F plasmid partition complex. Nucleic Acids Res (2011) 0.82
Labeling antibodies with fluorochromes. CSH Protoc (2006) 0.81
Development of a novel multiplex in vitro binding assay to profile p53-DNA interactions. Cell Cycle (2010) 0.81
Immunoblotting: antigen detection using chemiluminescence. CSH Protoc (2006) 0.80
Immunoaffinity purification: coupling antibodies to protein a or g bead columns. CSH Protoc (2006) 0.80
Partition operon expression in the linear plasmid prophage N15 is controlled by both Sop proteins and protelomerase. Mol Microbiol (2003) 0.79
Purification of antibodies on an antigen column. CSH Protoc (2006) 0.78
Bradford assay. CSH Protoc (2006) 0.78
Binding of Translationally Controlled Tumour Protein to the N-terminal domain of HDM2 is inhibited by nutlin-3. PLoS One (2012) 0.78
Immunoprecipitation: denaturing lysis. CSH Protoc (2006) 0.78
Immunoprecipitation: purifying the immune complexes. CSH Protoc (2006) 0.78
Mounting samples in gelvatol or mowiol. CSH Protoc (2006) 0.78
Preparing early whole-mount Drosophila embryos for immunostaining. CSH Protoc (2006) 0.78
On the role of centromere dispersion in stability of linear bacterial plasmids. Plasmid (2010) 0.77
Immunoprecipitation: lysing yeast cells using glass beads. CSH Protoc (2006) 0.76
Immunoaffinity purification: binding of antigen to antibody-bead matrix in a suspension. CSH Protoc (2006) 0.76
Staining immunoblots for total protein using ponceau s. CSH Protoc (2006) 0.76
Preparing frozen tissue sections for immunostaining. CSH Protoc (2006) 0.76
Detection of horseradish peroxidase-labeled reagents with aminoethylcarbazole. CSH Protoc (2006) 0.76
Extended function of plasmid partition genes: the Sop system of linear phage-plasmid N15 facilitates late gene expression. J Bacteriol (2008) 0.75
Double-blind review: easy to guess in specialist fields. Nature (2008) 0.75
Storage of ascitic fluid. CSH Protoc (2006) 0.75
Labeling monoclonal antibodies by biosynthesis. CSH Protoc (2006) 0.75
Immunoblotting: preparing immunoprecipitated proteins. CSH Protoc (2006) 0.75
Storage of sera. CSH Protoc (2006) 0.75
Labeling antibodies with biotin. CSH Protoc (2006) 0.75
Labeling antibodies with iodine. CSH Protoc (2006) 0.75
Indirect detection using fluorochrome-labeled reagents. CSH Protoc (2006) 0.75
Growing adherent cells directly on tissue dishes. CSH Protoc (2006) 0.75
Attaching suspension cells to slides using chemical linkers. CSH Protoc (2006) 0.75
Indirect detection using horseradish peroxidase-labeled reagents. CSH Protoc (2006) 0.75
Fixing attached cells in organic solvents. CSH Protoc (2006) 0.75
Fixing attached cells in paraformaldehyde. CSH Protoc (2006) 0.75
Fixing suspension cells with paraformaldehyde. CSH Protoc (2006) 0.75
Immunoblotting: preparing cell lysates. CSH Protoc (2006) 0.75
Growing adherent cells on coverslips or multiwell slides. CSH Protoc (2006) 0.75
Immunoblotting: preparing protein solutions. CSH Protoc (2006) 0.75
Attaching suspension cells to slides using a cytocentrifuge. CSH Protoc (2006) 0.75
Storage of tissue culture supernatants. CSH Protoc (2006) 0.75